Generic Emcure stole COVID-19 vaccine trade secrets, lawsuit claims
22-03-2022
Genevant signs $600m liver fibrosis deal with Takeda
18-03-2021
Pavel Kapysh / Shutterstock.com
Arbutus Biopharma and Genevant Sciences are jointly suing Moderna over royalties from the sales of its COVID-19 vaccine, which allegedly uses their tech for a drug-delivery system without authorisation.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
COVID-19, Arbutus, Genevant, sue, Moderna, dispute, vaccine, LNPs
